Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 9, 2010 - Issue 1
Submit an article Journal homepage
760
Views
75
CrossRef citations to date
0
Altmetric
Original Research

Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections

Elizabeth D Hermsen The Nebraska Medical Center, Department of Pharmaceutical and Nutrition Care, 984031 Omaha, NE 68918-4031, USA +1 402 559 4287; +1 402 559 8300; [email protected]; University of Nebraska Medical Center, College of Pharmacy, Department of Pharmacy Practice, Omaha, NE, USA; University of Nebraska Medical Center, College of Medicine, Section of Infectious Diseases, Department of Internal Medicine, Omaha, NE, USA
, PharmD, MBA, BCPS-ID,
Monica Hanson The Nebraska Medical Center, Department of Pharmaceutical and Nutrition Care, 984031 Omaha, NE 68918-4031, USA +1 402 559 4287; +1 402 559 8300; [email protected]
, PharmD,
Jayashri Sankaranarayanan University of Nebraska Medical Center, College of Pharmacy, Department of Pharmacy Practice, Omaha, NE, USA
, PhD,
Julie A Stoner University of Oklahoma Health Sciences Center, College of Public Health, Department of Biostatistics and Epidemiology, Oklahoma City, USA
, PhD,
Marius C Florescu University of Nebraska Medical Center, College of Medicine, Section of Nephrology, Department of Internal Medicine, Omaha, NE, USA
, MD &
Mark E Rupp University of Nebraska Medical Center, College of Medicine, Section of Infectious Diseases, Department of Internal Medicine, Omaha, NE, USA
, MD
Pages 9-14 | Published online: 20 Dec 2009

Bibliography

  • Hidayat LK, Hsu DI, Quist R, High-dose vancomycin therapy for methicillin-resistant staphylococcus aureus infections: efficacy and toxicity. Arch Intern Med 2006;166:2138-44
  • Lodise TP, Graves J, Evans A, Relationship between vancomycin MIC and failure among patients with methicillin-resistant staphylococcus aureus bacteremia treated with vancomycin. Antimicrob Agents Chemother 2008;52:3315-20
  • Sakoulas G, Moise-Broder PA, Schentag J, Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant staphylococcus aureus bacteremia. J Clin Microbiol 2004;42:2398-402
  • Soriano A, Marco F, Martinez JA, Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant staphylococcus aureus bacteremia. Clin Infect Dis 2008;46:193-200
  • Rybak M, Lomaestro B, Rotschafer JC, Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 2009;66:82-98
  • Sakoulas G, Eliopoulos GM, Moellering RC Jr, Staphylococcus aureus accessory gene regulator (agr) group II: is there a relationship to the development of intermediate-level glycopeptide resistance? J Infect Dis 2003;187:929-38
  • Jeffres MN, Isakow W, Doherty JA, Predictors of mortality for methicillin-resistant staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices. Chest 2006;130:947-55
  • Jeffres MN, Isakow W, Doherty JA, A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant staphylococcus aureus pneumonia. Clin Ther 2007;29:1107-15
  • Deresinski S. Counterpoint: vancomycin and staphylococcus aureus – an antibiotic enters obsolescence. Clin Infect Dis 2007;44:1543-8
  • Stevens DL. The role of vancomycin in the treatment paradigm. Clin Infect Dis 2006;42(Suppl 1):S51-7
  • American Thoracic Society and the Infectious Diseases Society of America. Niederman MS, Craven DE, Bonten MJ, Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416
  • Lodise TP, Lomaestro B, Graves J, Drusano GL. Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity. Antimicrob Agents Chemother 2008;52:1330-6
  • Lodise TP, Patel N, Lomaestro BM, Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients. Clin Infect Dis 2009;49:507-14

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.